Medicamen Biotech Limited (MEDICAMEQ.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹263.55 (-0.90%) as of
Key statistics
- Market cap
- 3.57B
- P/E (TTM)
- 35.57
- Forward P/E
- 21.75
- EPS (TTM)
- 7.41
- Dividend yield
- 0.38%
- 52-week range
- 210.10 – 454.00
- Beta
- 0.69
- Revenue (TTM)
- 2.06B
- Profit margin
- 4.66%
- Volume
- 195.00
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins and supplements, antibiotics, pain management, and other generics. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- New Delhi, India
- Employees
- 405
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.